Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

DrugBank

Drug (Description in trials)

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[3] Valproate; VALPROATE SODIUM; Valproic acid

[1] Valproic acid 💬

[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬

Name	Full Name
ABAT	4-aminobutyrate aminotransferase
ALDH5A1	aldehyde dehydrogenase 5 family member A1
CACNA1G	calcium voltage-gated channel subunit alpha1 G
CACNA1H	calcium voltage-gated channel subunit alpha1 H
CACNA1I	calcium voltage-gated channel subunit alpha1 I
GAD1	glutamate decarboxylase 1
GAD2	glutamate decarboxylase 2

[17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬

[14] 2, 3, 5, 6, 13, 26, 65, 85, 90, 102, 127, 222, 233, 256 💬

Disease ID	Name
2	Amyotrophic lateral sclerosis
3	Spinal muscular atrophy
5	Progressive supranuclear palsy
6	Parkinson disease
13	Multiple sclerosis/Neuromyelitis optica
26	HTLV-1-associated myelopathy
65	Primary immunodeficiency
85	Idiopathic interstitial pneumonia
90	Retinitis pigmentosa
102	Rubinstein-Taybi syndrome
127	Frontotemporal lobar degeneration
222	Primary nephrotic syndrome
233	Wolfram syndrome
256	Muscle glycogenosis